10 Best Defensive Stocks to Buy According to Steve Cohen

2. Boston Scientific Corporation (NYSE:BSX)

Point72 Asset Management Equity Stake: $264.30 Million

Number of Hedge Fund Holders: 100

Boston Scientific Corporation (NYSE:BSX) is one of the best defensive stocks to buy, according to Steve Cohen. On September 8, analysts at Oppenheimer upgraded the stock to an ‘Outperform’ from Perform and reiterated a $125 price target.

The upgrade comes as Oppenheimer views the company as one of the best large-cap MedTech growth stories owing to a robust merger and acquisition strategy. The company has delivered a strong performance, with 21.44% revenue growth over the past 12 months.

In addition, the research firm has echoed the company’s projected 11%-13% compound annual growth rate outlook. It is a positive attribute for a highly diversified company in the healthcare sector. Its competitive edge was the catalyst behind a 17% organic revenue growth in the second quarter of 2025 as earnings per share increased 23%.

Boston Scientific Corporation (NYSE:BSX) is a global medical technology company that develops and manufactures innovative devices and solutions to diagnose and treat a wide range of complex medical conditions, including cardiovascular, respiratory, digestive, neurological, and urological diseases.